PneumoniaNCT02738645
A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit
An observational study of Pneumonia, run by Beijing Chao Yang Hospital at 1 site in China.
Trial summary
From 2003 when Severe Acute Respiratory Syndromes (SARS) appeared，many new types of respiratory viruses emerge in endlessly. Therefore, the epidemiology and the clinical character has changed quietly, especially severe pneumonia. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Pneumonia
- What is being tested?
- pneumonia
- How many people
- 800 participants
- Where
- 1 siteChina
- Study dates
- Jun 2016to 31 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: the patients of RICU
Who may be able to join
- admit in RICU because of pneumonia of any causes
- anticipated length of hospital stay more than 72h
Who cannot join
- admit in RICU because of other causes except pneumonia
- do not agree to join this study
- admit in RICU for the second time
- anticipated length of hospital stay less than 72h
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
Department of respiratory and critical care medicine,Beijing Chao-yang Hospital
Beijing, Beijing Municipality, 100020
Bing Sun, MD, 86013911151075, ricusunbing@126.com
Xiao Tang, MD, 86013811089795, tangxiao0928@163.com
About this study
From 2003 when Severe Acute Respiratory Syndromes (SARS) appeared，many new types of respiratory viruses emerge in endlessly. Therefore, the epidemiology and the clinical character has changed quietly, especially severe pneumonia. This cohort study aim to obtain the contents of severe pneumonia patients in Respiratory Intensive Care Unit (RICU). Through the clinical data analysis, the investigators could get the information of the pneumonia caused by different reasons, such as morbidity and mortality, risk factors, clinical symptoms and radiographic changes, the respiratory support parameter and so on. The investigators hope the result could guide them do the clinical work of severe pneumonia better in the future.
- Conditions
- Pneumonia
- Being tested
- pneumonia
- Medical subject headings
- Pneumonia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
pneumoniaOther
| Study group | Role | What they receive |
|---|---|---|
| pneumonia in RICU | The patients admit in RICU because of pneumonia. Receives: Other: pneumonia |
What is being measured
The primary outcome is the main question the study is designed to answer.
the mortality caused by any reasons in RICU
Measured: one years
the morbidity caused by any reasons in RICU
Measured: one years
Secondary outcomes (3)
the symptoms description of pneumonia caused by any reasons in RICU
all the symptoms caused by pneumonia, such as fever, cough, dyspnea, sputum and so on. The investigators could get the incidence of each of these symptoms.
Measured: the first 48hours after admitted in RICU
the respiratory support of pneumonia caused by any reasons in RICU
summarize the respiratory support parameters while the patients hospitalized in RICU. For example, the ventilation parameter and mode, Whether the mechanical ventilation complications occurred, and so on.
Measured: the first 5 days after admitted in RICU
the treatment options of pneumonia caused by any reasons in RICU
the investigators obtain the treatment commons, such as the kind of antibiotics, the dosage of glucocorticoids, etc.
Measured: 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2016 (estimated)
- Study startJun 2016
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PneumoniaStudies of the same condition, open and under way.
- More trials run by Beijing Chao Yang HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 800 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Beijing Chao Yang Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Xiao Tang, Beijing Chao Yang Hospital
- Investigators
- Bing Sun, Dr, Principal investigator, Beijing Chao-Yang Hospital, China
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02738645
- Sponsor's protocol ID
- Pneumonia RICU
- Status last verified
- Oct 2025
- First submitted
- 26 Mar 2016
- Last updated
- 18 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 18 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit
- ClinicalTrials.gov ID
- NCT02738645
- Acronym / sponsor ID
- Pneumonia RICU
- Conditions
- Pneumonia
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 800 participants (estimated)
- Lead sponsor
- Beijing Chao Yang HospitalUniversity, hospital or other
- Study start
- Jun 2016 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 14 Apr 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
From 2003 when Severe Acute Respiratory Syndromes (SARS) appeared，many new types of respiratory viruses emerge in endlessly. Therefore, the epidemiology and the clinical character has changed quietly, especially severe pneumonia. This cohort study aim to obtain the contents of severe pneumonia patients in Respiratory Intensive Care Unit (RICU). Through the clinical data analysis, the investigators could get the information of the pneumonia caused by different reasons, such as morbidity and mortality, risk factors, clinical symptoms and radiographic changes, the respiratory support parameter and so on. The investigators hope the result could guide them do the clinical work of severe pneumonia better in the future.
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| pneumonia in RICU | – | Other: pneumoniaThe patients admit in RICU because of pneumonia. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- the patients of RICU
Key inclusion criteria (2 listed)
- admit in RICU because of pneumonia of any causes
- anticipated length of hospital stay more than 72h
Key exclusion criteria (4 listed)
- admit in RICU because of other causes except pneumonia
- do not agree to join this study
- admit in RICU for the second time
- anticipated length of hospital stay less than 72h
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| pneumonia | Other | pneumonia in RICU |
Primary outcome
the mortality caused by any reasons in RICU
Time frame: one years
the morbidity caused by any reasons in RICU
Time frame: one years
3 secondary outcomes
the symptoms description of pneumonia caused by any reasons in RICU
Time frame: the first 48hours after admitted in RICU
the respiratory support of pneumonia caused by any reasons in RICU
Time frame: the first 5 days after admitted in RICU
the treatment options of pneumonia caused by any reasons in RICU
Time frame: 3 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Mar 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Pneumonia
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Not yet recruiting
Expanded Diagnostic Strategy in Older Adults Hospitalized With Community-Acquired Acute Respiratory Infection
Acute Respiratory Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Bing Sun, Dr principal investigator
Beijing Chao-Yang Hospital, China
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pneumonia, run by Beijing Chao Yang Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 18 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Bing Sun, Dr (86013911151075, ricusunbing@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the mortality caused by any reasons in RICU (time frame: one years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2026.